Pharma Foods International Co., Ltd. (2929.T)
JPY 910.0
(1.68%)
JPY 910.0
(1.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 1.22 Billion JPY | -67.68% |
| 2023 | 3.79 Billion JPY | -52.7% |
| 2022 | 8.01 Billion JPY | 263.61% |
| 2021 | -4.89 Billion JPY | -1754.2% |
| 2020 | 296.03 Million JPY | 124.48% |
| 2019 | -1.2 Billion JPY | 20.52% |
| 2018 | -1.52 Billion JPY | -19.19% |
| 2017 | -1.27 Billion JPY | 10.24% |
| 2016 | -1.42 Billion JPY | 5.59% |
| 2015 | -1.5 Billion JPY | 0.19% |
| 2014 | -1.5 Billion JPY | -51.38% |
| 2013 | -997.19 Million JPY | -44.88% |
| 2012 | -688.27 Million JPY | -169.01% |
| 2011 | -255.85 Million JPY | 9.18% |
| 2010 | -281.7 Million JPY | 45.08% |
| 2009 | -512.89 Million JPY | 20.34% |
| 2008 | -643.87 Million JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 2.68 Billion JPY | -7.64% |
| 2024 Q4 | 1.22 Billion JPY | -54.34% |
| 2024 Q1 | 2.74 Billion JPY | -27.7% |
| 2024 Q2 | 2.9 Billion JPY | 6.02% |
| 2023 Q1 | 6.57 Billion JPY | -17.92% |
| 2023 FY | 3.79 Billion JPY | -52.7% |
| 2023 Q2 | 7.46 Billion JPY | 13.47% |
| 2023 Q3 | 6.43 Billion JPY | -13.83% |
| 2023 Q4 | 3.79 Billion JPY | -41.06% |
| 2022 FY | 8.01 Billion JPY | 263.61% |
| 2022 Q3 | 5.11 Billion JPY | 323.26% |
| 2022 Q4 | 8.01 Billion JPY | 56.7% |
| 2022 Q1 | 1.5 Billion JPY | 130.81% |
| 2022 Q2 | 1.2 Billion JPY | -19.95% |
| 2021 Q2 | -178.33 Million JPY | -143.51% |
| 2021 Q4 | -4.89 Billion JPY | -95.32% |
| 2021 FY | -4.89 Billion JPY | -1754.2% |
| 2021 Q1 | 409.91 Million JPY | 38.47% |
| 2021 Q3 | -2.5 Billion JPY | -1305.86% |
| 2020 Q3 | 1.1 Billion JPY | 261.96% |
| 2020 Q1 | -732.38 Million JPY | 39.44% |
| 2020 FY | 296.03 Million JPY | 124.48% |
| 2020 Q2 | 305.73 Million JPY | 141.75% |
| 2020 Q4 | 296.03 Million JPY | -73.25% |
| 2019 Q4 | -1.2 Billion JPY | 21.69% |
| 2019 FY | -1.2 Billion JPY | 20.52% |
| 2019 Q1 | -2.23 Billion JPY | -46.72% |
| 2019 Q2 | -1.65 Billion JPY | 25.93% |
| 2019 Q3 | -1.54 Billion JPY | 6.61% |
| 2018 Q1 | -1.57 Billion JPY | -23.45% |
| 2018 Q3 | -1.13 Billion JPY | -21.93% |
| 2018 Q2 | -929.27 Million JPY | 41.04% |
| 2018 FY | -1.52 Billion JPY | -19.19% |
| 2018 Q4 | -1.52 Billion JPY | -34.3% |
| 2017 Q4 | -1.27 Billion JPY | -26.24% |
| 2017 FY | -1.27 Billion JPY | 10.24% |
| 2017 Q1 | -1.56 Billion JPY | -10.36% |
| 2017 Q2 | -1.01 Billion JPY | 35.42% |
| 2017 Q3 | -1.01 Billion JPY | 0.24% |
| 2016 FY | -1.42 Billion JPY | 5.59% |
| 2016 Q1 | -1.68 Billion JPY | -11.57% |
| 2016 Q2 | -1.17 Billion JPY | 30.1% |
| 2016 Q3 | -1.28 Billion JPY | -9.48% |
| 2016 Q4 | -1.42 Billion JPY | -10.58% |
| 2015 Q1 | -1.55 Billion JPY | -2.76% |
| 2015 Q3 | -1.51 Billion JPY | -2.98% |
| 2015 Q4 | -1.5 Billion JPY | 0.4% |
| 2015 Q2 | -1.46 Billion JPY | 5.3% |
| 2015 FY | -1.5 Billion JPY | 0.19% |
| 2014 Q2 | -803.86 Million JPY | 3.25% |
| 2014 FY | -1.5 Billion JPY | -51.38% |
| 2014 Q4 | -1.5 Billion JPY | 2.95% |
| 2014 Q3 | -1.55 Billion JPY | -93.49% |
| 2014 Q1 | -830.88 Million JPY | 16.68% |
| 2013 Q3 | -895.06 Million JPY | 0.21% |
| 2013 Q4 | -997.19 Million JPY | -11.41% |
| 2013 FY | -997.19 Million JPY | -44.88% |
| 2013 Q1 | -760.64 Million JPY | -10.51% |
| 2013 Q2 | -896.91 Million JPY | -17.91% |
| 2012 Q3 | -564.51 Million JPY | -127.44% |
| 2012 FY | -688.27 Million JPY | -169.01% |
| 2012 Q1 | -238.17 Million JPY | 6.91% |
| 2012 Q4 | -688.27 Million JPY | -21.92% |
| 2012 Q2 | -248.2 Million JPY | -4.21% |
| 2011 Q1 | -226.44 Million JPY | 19.61% |
| 2011 Q4 | -255.85 Million JPY | 13.35% |
| 2011 FY | -255.85 Million JPY | 9.18% |
| 2011 Q3 | -295.26 Million JPY | 3.79% |
| 2011 Q2 | -306.89 Million JPY | -35.53% |
| 2010 Q1 | -457.97 Million JPY | 10.71% |
| 2010 Q3 | -285.81 Million JPY | 23.69% |
| 2010 FY | -281.7 Million JPY | 45.08% |
| 2010 Q4 | -281.7 Million JPY | 1.44% |
| 2010 Q2 | -374.52 Million JPY | 18.22% |
| 2009 Q3 | -35.36 Million JPY | -1.63% |
| 2009 Q2 | -34.79 Million JPY | 0.0% |
| 2009 Q4 | -512.89 Million JPY | -1350.37% |
| 2009 FY | -512.89 Million JPY | 20.34% |
| 2008 FY | -643.87 Million JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.972% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 99.686% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 100.354% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 134.37% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 102.906% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 101.993% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 101.251% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 283.658% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 102.364% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 103.721% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 83.886% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 84.257% |
| Tsumura & Co. | 1.61 Billion JPY | 24.149% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 102.774% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 103.557% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 99.291% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 95.399% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 95.773% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 82.649% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -74.006% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 79.556% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 118.797% |
| MedRx Co., Ltd | -1.72 Billion JPY | 171.221% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 114.054% |
| Solasia Pharma K.K. | -668 Million JPY | 283.383% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 183.28% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 116.89% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 97.833% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 141.374% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 101.245% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 111.007% |